|Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data|
SJ Tabrizi, DR Langbehn, BR Leavitt, RAC Roos, A Durr, D Craufurd, ...
The Lancet Neurology 8 (9), 791-801, 2009
|Huntington disease: natural history, biomarkers and prospects for therapeutics|
CA Ross, EH Aylward, EJ Wild, DR Langbehn, JD Long, JH Warner, ...
Nature Reviews Neurology 10 (4), 204-216, 2014
|Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data|
SJ Tabrizi, RI Scahill, G Owen, A Durr, BR Leavitt, RA Roos, B Borowsky, ...
The Lancet Neurology 12 (7), 637-649, 2013
G Bates, R Dorsey, J Gusella, M Hayden, C Kay, B Leavitt, M Nance, ...
Nature Reviews DIsease Primers, 15005, 2015
|A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's disease|
M Björkqvist, EJ Wild, J Thiele, A Silvestroni, R Andre, N Lahiri, ...
The Journal of experimental medicine 205 (8), 1869-1877, 2008
|Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis|
SJ Tabrizi, RI Scahill, A Durr, RAC Roos, BR Leavitt, R Jones, ...
The Lancet Neurology 10 (1), 31-42, 2011
|Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data|
SJ Tabrizi, R Reilmann, RAC Roos, A Durr, B Leavitt, G Owen, R Jones, ...
The Lancet Neurology 11 (1), 42-53, 2012
|CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion|
JM Lee, EM Ramos, JH Lee, T Gillis, JS Mysore, MR Hayden, SC Warby, ...
Neurology 78 (10), 690-695, 2012
|Proteomic profiling of plasma in Huntington's disease reveals neuroinflammatory activation and biomarker candidates|
A Dalrymple, EJ Wild, R Joubert, K Sathasivam, M Bj÷rkqvist, ┼ PetersÚn, ...
Journal of proteome research 6 (7), 2833-2840, 2007
|Rapid eye movement sleep disturbances in Huntington disease|
I Arnulf, J Nielsen, E Lohmann, J Schieffer, E Wild, P Jennum, E Konofal, ...
Archives of neurology 65 (4), 482-488, 2008
|Targeting Huntingtin Expression in Patients with Huntington’s Disease|
SJ Tabrizi, BR Leavitt, GB Landwehrmeyer, EJ Wild, C Saft, RA Barker, ...
New England Journal of Medicine, 2019
|C9orf72 expansions are the most common genetic cause of Huntington disease phenocopies|
DJH Moss, M Poulter, J Beck, J Hehir, JM Polke, T Campbell, G Adamson, ...
Neurology 82 (4), 292-299, 2014
|Quantification of mutant huntingtin protein in cerebrospinal fluid from Huntington’s disease patients|
EJ Wild, R Boggio, D Langbehn, N Robertson, S Haider, JRC Miller, ...
The Journal of clinical investigation 125 (5), 1979-1986, 2015
|Targets for future clinical trials in Huntington's disease: what's in the pipeline?|
EJ Wild, SJ Tabrizi
Movement Disorders 29 (11), 1434-1445, 2014
|Therapies targeting DNA and RNA in Huntington's disease|
EJ Wild, SJ Tabrizi
The Lancet Neurology 16 (10), 837-847, 2017
|Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington's disease: a retrospective cohort analysis|
LM Byrne, FB Rodrigues, K Blennow, A Durr, BR Leavitt, RAC Roos, ...
The Lancet Neurology 16 (8), 601-609, 2017
|Analysis of potential transcriptomic biomarkers for Huntington's disease in peripheral blood|
H Runne, A Kuhn, EJ Wild, W Pratyaksha, M Kristiansen, JD Isaacs, ...
Proceedings of the National Academy of Sciences 104 (36), 14424-14429, 2007
|Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study|
DJH Moss, AF Pardi˝as, D Langbehn, K Lo, BR Leavitt, R Roos, A Durr, ...
The Lancet Neurology 16 (9), 701-711, 2017
|The differential diagnosis of chorea|
EJ Wild, SJ Tabrizi
Practical neurology 7 (6), 360-373, 2007
|Mutant huntingtin causes defective actin remodeling during stress: defining a new role for transglutaminase 2 in neurodegenerative disease|
L Munsie, N Caron, RS Atwal, I Marsden, EJ Wild, JR Bamburg, SJ Tabrizi, ...
Human molecular genetics 20 (10), 1937-1951, 2011